Search research articles
Contact Us
Filters
Showing results (521-530 of 542) with videos related to
Page
of 55
Sort By:
Journal of Clinical Microbiology
|
November 14, 2008
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing
M A Pfaller, D J Diekema, D L Gibbs, et al.
Journal of Clinical Microbiology
|
September 17, 1998
Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci
Y S Chen, S A Marshall, P L Winokur, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1996
Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study
E J Anaissie, V L Paetznick, L G Ensign, et al.
Clinical Microbiology Reviews
|
October 5, 2001
Antifungal susceptibility testing: practical aspects and current challenges
J H Rex, M A Pfaller, T J Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1997
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards
J H Rex, M A Pfaller, J N Galgiani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 22, 2001
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey
H M Blumberg, W R Jarvis, J M Soucie, et al.
Journal of Clinical Microbiology
|
June 27, 2008
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints
M A Pfaller, D J Diekema, L Ostrosky-Zeichner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 19, 1999
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance
A S Kao, M E Brandt, W R Pruitt, et al.
Journal of Clinical Microbiology
|
August 17, 1999
Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3
F Marco, S R Lockhart, M A Pfaller, et al.
Journal of Clinical Microbiology
|
March 7, 2006
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints
M A Pfaller, D J Diekema, J H Rex, et al.
Page
of 55
Search research articles
Search
Showing results (521-530 of 542) with videos related to
Sort By:
Page
of 55
Journal of Clinical Microbiology
|
November 14, 2008
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing
M A Pfaller, D J Diekema, D L Gibbs, et al.
Journal of Clinical Microbiology
|
September 17, 1998
Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci
Y S Chen, S A Marshall, P L Winokur, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1996
Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study
E J Anaissie, V L Paetznick, L G Ensign, et al.
Clinical Microbiology Reviews
|
October 5, 2001
Antifungal susceptibility testing: practical aspects and current challenges
J H Rex, M A Pfaller, T J Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1997
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards
J H Rex, M A Pfaller, J N Galgiani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 22, 2001
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey
H M Blumberg, W R Jarvis, J M Soucie, et al.
Journal of Clinical Microbiology
|
June 27, 2008
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints
M A Pfaller, D J Diekema, L Ostrosky-Zeichner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 19, 1999
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance
A S Kao, M E Brandt, W R Pruitt, et al.
Journal of Clinical Microbiology
|
August 17, 1999
Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3
F Marco, S R Lockhart, M A Pfaller, et al.
Journal of Clinical Microbiology
|
March 7, 2006
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints
M A Pfaller, D J Diekema, J H Rex, et al.
Page
of 55